Immunovant
IMVT
#3766
Rank
โ‚น215.00 B
Marketcap
โ‚น1,266
Share price
2.70%
Change (1 day)
-46.88%
Change (1 year)

Immunovant (IMVT) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น5.82 Billion

According to Immunovant's latest financial reports the company's total liabilities are โ‚น5.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Immunovant - Total liabilities on balance sheet (from 2019 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-03-31โ‚น4.05 B13.9%
2023-03-31โ‚น3.55 B2.6%
2022-03-31โ‚น3.46 B124.77%
2021-03-31โ‚น1.54 B33.6%
2020-03-31โ‚น1.15 B
2018-12-31โ‚น26.6 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น2.64 B-54.59%๐Ÿ‡บ๐Ÿ‡ธ USA